A Phase 1 Study of BRG01 in Subjects With Relapsed/Metastatic Epstein-Barr Virus (EBV)-Positive Nasopharyngeal Carcinoma

Clinical trial NCT05864924 · COMPLETED

Trial details

NCT number: NCT05864924
Sponsor: BioSyngen Pte Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

EBV-positive Nasopharyngeal Carcinoma

Start date: 2023-05-10
Primary completion: 2024-04-26
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.